Helius Medical Technologies (HSDT) Price & Analysis

Compare

321 Followers

HSDT Stock Chart & Stats

Day’s Range― - ―

52-Week Range$5.37 - $1,200.00

Previous CloseN/A

Volume68.49K

Average Volume (3M)708.58K

Market Cap

$3.93M

Enterprise Value$1.92M

Total Cash (Recent Filing)$1.11M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta-0.34

Next Earnings

Aug 07, 2025

EPS Estimate

-128.5

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding676,000

10 Day Avg. Volume74,000

30 Day Avg. Volume708,579

Financial Highlights & Ratios

PEG Ratio1.65

Price to Book (P/B)1.29K

Price to Sales (P/S)2618.59

P/FCF Ratio-123.27

Enterprise Value/Market Cap0.49

Enterprise Value/Revenue4.43

Enterprise Value/Gross Profit-13.16

Enterprise Value/Ebitda-0.13

Forecast

1Y Price Target

$6.20

Price Target Upside5.08% Upside

Rating ConsensusHold

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Clinical Study ResultsHSDT announced positive results from the PoNS Therapeutic Experience Program, or PoNSTEP, study for people with multiple sclerosis.

Healthcare Provider ReimbursementHSDT announced its first reimbursement payment from a healthcare provider for its PoNS Device.

Insurance CoverageUnitedHealthcare has approved reimbursement for the PoNS device, adding a second private payer to provide coverage.

Bears Say

CMS Reimbursement DecisionThe unfavorable CMS reimbursement decision remains a significant barrier, limiting access to a key patient population and dampening near-term US revenue potential.

Reimbursement ChallengesThe ongoing reimbursement headwind continues to limit access to key patient populations and suppress near-term growth.

Revenue PerformanceHSDT reported lower-than-expected 1Q25 revenue, as adoption of the PoNS device remains inconsistent.

Helius Medical Technologies News

Why Is Helius Medical Technologies Stock (HSDT) Up 70% Today?

Helius Medical Technologies stock soared after it announced positive outcomes for its PoNS SRP. ...

23d ago

HSDT

Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!

TipRanks offers the hottest stock market stories traders need to read about on Monday! ...

23d ago

AMD

Helius Medical announces outcome of PoNS Stroke Registrational Program

Helius Medical (HSDT) Technologies announced positive outcome from the PoNS Stroke Registrational Program supporting a planned FDA submission...

24d ago

HSDT

Helius Medical Announces Success in PoNS Stroke Program

The latest announcement is out from Helius Medical Technologies ( ($HSDT) ). On July 21, 2025, Helius Medical...

24d ago

HSDT

Helius Medical Regains Nasdaq Compliance

Helius Medical Technologies ( ($HSDT) ) has shared an update. On July 7, 2025, Helius Medical Technologies announced...

1M ago

HSDT

Helius Medical receives compliance letter from Nasdaq

Helius Medical (HSDT) Technologies announced that on July 7 Helius received formal notice from the Nasdaq Hearings Panel...

1M ago

HSDT

Helius Medical Files $25M Stock Offering Prospectus

The latest announcement is out from Helius Medical Technologies ( ($HSDT) ). On July 7, 2025, Helius Medical...

1M ago

HSDT

Helius Medical Technologies Inc trading halted, news pending

19:50 EDT Helius Medical (HSDT) Technologies Inc trading halted, news pending Published first on TheFly – the ultimate...

1M ago

HSDT

Upcoming Stock Splits This Week (June 30 to July 4) – Stay Invested

These are the upcoming stock splits for the week of June 30 to July 4, based on TipRanks’ Stock...

2M ago

APG

AIMD

Helius Medical Approves Reverse Stock Split Plan

An update from Helius Medical Technologies ( ($HSDT) ) is now available. On June 20, 2025, Helius Medical...

2M ago

HSDT

Helius Medical announces 1-for-50 reverse stock split

Helius Medical (HSDT) Technologies announced a 1-for-50 reverse split of its Class A common stock, par value $0.001,...

2M ago

HSDT

Helius Medical Raises $8.1M to Meet Nasdaq Compliance

The latest update is out from Helius Medical Technologies ( ($HSDT) ). Helius Medical Technologies, Inc. faced a...

2M ago

HSDT

Helius Medical Expands Equity Plan Amid Share Increase

An announcement from Helius Medical Technologies ( ($HSDT) ) is now available. Helius Medical Technologies announced that its...

2M ago

HSDT

Helius Medical announces claim authorization by CignaHealth for PoNS Device

Helius Medical (HSDT) Technologies announced an additional authorized claim for payment for the PoNS Device from CignaHealth. CignaHealth...

2M ago

HSDT

HSDT FAQ

What was Helius Medical Technologies’s price range in the past 12 months?

Helius Medical Technologies lowest stock price was $5.37 and its highest was $1200.00 in the past 12 months.

What is Helius Medical Technologies’s market cap?

Helius Medical Technologies’s market cap is $3.93M.

When is Helius Medical Technologies’s upcoming earnings report date?

Helius Medical Technologies’s upcoming earnings report date is Aug 07, 2025 which is 6 days ago.

How were Helius Medical Technologies’s earnings last quarter?

Helius Medical Technologies released its earnings results on May 08, 2025. The company reported -$8.7 earnings per share for the quarter, the consensus estimate of -$8.7 by $0.

Is Helius Medical Technologies overvalued?

According to Wall Street analysts Helius Medical Technologies’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Helius Medical Technologies pay dividends?

Helius Medical Technologies does not currently pay dividends.

What is Helius Medical Technologies’s EPS estimate?

Helius Medical Technologies’s EPS estimate is -128.5.

How many shares outstanding does Helius Medical Technologies have?

Helius Medical Technologies has 676,000 shares outstanding.

What happened to Helius Medical Technologies’s price movement after its last earnings report?

Helius Medical Technologies reported an EPS of -$8.7 in its last earnings report, expectations of -$8.7. Following the earnings report the stock price went up 3.784%.

Which hedge fund is a major shareholder of Helius Medical Technologies?

Currently, no hedge funds are holding shares in HSDT

Company Description

Helius Medical Technologies

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Helius Medical Technologies (HSDT) Earnings & Revenues

Historic Earnings Reports

HSDT Stock 12 Month Forecast

Average Price Target

$6.20

▲(5.08% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","4216":"$4,216","1054.75":"$1,054.8","2108.5":"$2,108.5","3162.25":"$3,162.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$9.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,1054.75,2108.5,3162.25,4216],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.1,6.361538461538461,6.623076923076923,6.884615384615384,7.146153846153846,7.407692307692307,7.669230769230769,7.930769230769231,8.192307692307692,8.453846153846154,8.715384615384615,8.976923076923077,9.23846153846154,{"y":9.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.1,6.107692307692307,6.115384615384615,6.123076923076923,6.13076923076923,6.138461538461538,6.146153846153846,6.153846153846154,6.161538461538462,6.1692307692307695,6.176923076923077,6.184615384615385,6.1923076923076925,{"y":6.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.1,5.8538461538461535,5.607692307692307,5.361538461538461,5.115384615384615,4.869230769230769,4.623076923076923,4.3769230769230765,4.13076923076923,3.8846153846153846,3.6384615384615384,3.3923076923076922,3.146153846153846,{"y":2.9,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3420,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4215.07,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2700,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":520.05,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":389.7,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.5,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":502.72,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":355.12,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":329.25,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":195.08,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":182.75,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.6,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":6.1,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >